Mel Sorensen insider trades: Galera Therapeutics (GRTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mel reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | GRTX | ↓ Sell | 70,000 | $0.02 | $1K | Direct | Nov 24, 2025 (4d) |
| Aug 16, 2024 | GRTX | ↓ Sell | 67,015 | $0.07 | $5K | Direct | Aug 20, 2024 (4d) |
| Mar 10, 2023 | GRTX | ↑ Buy | 100,000 | $1.68 | $168K | Direct | Mar 14, 2023 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mel Sorensen's insider trades
Mel Sorensen is President and CEO at Galera Therapeutics (GRTX). Since Mar 10, 2023, Mel has reported 1 open-market purchase worth $168K and 2 sales worth $6K on SEC Form 4. In the last 12 months: 1 sale ($1K).
Their filings also include grants and awards (5 filings), shares returned to the company (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.